FDA Approves Polypill Widaplik for Hypertension
Physician's Weekly
JUNE 11, 2025
Food and Drug Administration has approved Widaplik (telmisartan, amlodipine, and indapamide) for the treatment of hypertension in adults. The FDA approval is based on positive results from two international phase 3 trials that compared Widaplik to dual combinations of its component drugs as well as to placebo. All rights reserved.
Let's personalize your content